CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for L&C Bio Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

L&C Bio Co Ltd
605-607, Suntech city, 474
Dunchon-daero, Jungwon-gu
Phone: +82 317762975p:+82 317762975 SEONGNAM, 13229  South Korea Ticker: 290650290650
Business Summary
L&C Bio Co Ltd is a Korea-based company principally engaged in the medical business. The Company primarily manufactures and sells tissue engineering therapeutic materials such as human tissue grafts and human tissue-based medical devices. The Company also manufactures and supplies cosmeceuticals. The Company also engages in pharmaceuticals, functional cosmetics, health functional foods, and imaging devices.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Co-Chief Executive Officer, Chief Financial Officer, Director Jae HoLee 49 3/4/2025 3/4/2025
Co-Chief Executive Officer, Director Hwan CheolLee 48 3/4/2025
Vice President, Director Hyeong GuKim 56
8 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 22,684,891 (As of 12/31/2024)
Shareholders: 12,152
Stock Exchange: KDQ
Fax Number: +82 25418578


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 18, 2025